ENHERTU® PLUS PERTUZUMAB RECOMMENDED FOR APPROVAL IN THE EU BY CHMP AS FIRST-LINE TREATMENT FOR PATIENTS WITH HER2 POSITIVE METASTATIC BREAST CANCER

Reuters · 3d ago

Please log in to view news